Literature DB >> 33771493

The association of plasma IL-6 with measures of asthma morbidity in a moderate-severe pediatric cohort aged 6-18 years.

Perdita Permaul1, Michael C Peters2, Carter R Petty3, Juan Carlos Cardet4, Ngoc P Ly5, Sima K Ramratnam6, Kristie Ross7, Anne Fitzpatrick8, Elliot Israel9, Leonard B Bacharier10, Wanda Phipatanakul11.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33771493      PMCID: PMC8277679          DOI: 10.1016/j.jaip.2021.02.047

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


× No keyword cloud information.
  9 in total

1.  Treatment of severe persistent asthma with IL-6 receptor blockade.

Authors:  Brittany Esty; Hani Harb; Lisa M Bartnikas; Louis M Charbonnier; Amir H Massoud; Carmen Leon-Astudillo; Gary Visner; Meera Subramaniam; Wanda Phipatanakul; Talal A Chatila
Journal:  J Allergy Clin Immunol Pract       Date:  2019-03-15

2.  Serum IL-6: A biomarker in childhood asthma?

Authors:  Daniel J Jackson; Leonard B Bacharier; Agustin Calatroni; Michelle A Gill; Jack Hu; Andrew H Liu; Lisa M Wheatley; James E Gern; Rebecca S Gruchalla; Gurjit K Khurana Hershey; Meyer Kattan; Carolyn M Kercsmar; Haejin Kim; George T O'Connor; Shilpa Patel; Jacqueline A Pongracic; Robert A Wood; William W Busse
Journal:  J Allergy Clin Immunol       Date:  2020-01-28       Impact factor: 10.793

3.  C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus.

Authors:  A D Pradhan; J E Manson; N Rifai; J E Buring; P M Ridker
Journal:  JAMA       Date:  2001-07-18       Impact factor: 56.272

4.  Evidence for Exacerbation-Prone Asthma and Predictive Biomarkers of Exacerbation Frequency.

Authors:  Michael C Peters; David Mauger; Kristie R Ross; Brenda Phillips; Benjamin Gaston; Juan Carlos Cardet; Elliot Israel; Bruce D Levy; Wanda Phipatanakul; Nizar N Jarjour; Mario Castro; Sally E Wenzel; Annette Hastie; Wendy Moore; Eugene Bleecker; John V Fahy; Loren C Denlinger
Journal:  Am J Respir Crit Care Med       Date:  2020-10-01       Impact factor: 21.405

5.  Epithelial IL-6 trans-signaling defines a new asthma phenotype with increased airway inflammation.

Authors:  Zala Jevnikar; Jörgen Östling; Elisabeth Ax; Jenny Calvén; Kristofer Thörn; Elisabeth Israelsson; Lisa Öberg; Akul Singhania; Laurie C K Lau; Susan J Wilson; Jonathan A Ward; Anoop Chauhan; Ana R Sousa; Bertrand De Meulder; Matthew J Loza; Frédéric Baribaud; Peter J Sterk; Kian Fan Chung; Kai Sun; Yike Guo; Ian M Adcock; Debbie Payne; Barbro Dahlen; Pascal Chanez; Dominick E Shaw; Norbert Krug; Jens M Hohlfeld; Thomas Sandström; Ratko Djukanovic; Anna James; Timothy S C Hinks; Peter H Howarth; Outi Vaarala; Marleen van Geest; Henric Olsson
Journal:  J Allergy Clin Immunol       Date:  2018-06-11       Impact factor: 10.793

6.  Plasma interleukin-6 concentrations, metabolic dysfunction, and asthma severity: a cross-sectional analysis of two cohorts.

Authors:  Michael C Peters; Kelly Wong McGrath; Gregory A Hawkins; Annette T Hastie; Bruce D Levy; Elliot Israel; Brenda R Phillips; David T Mauger; Suzy A Comhair; Serpil C Erzurum; Mats W Johansson; Nizar N Jarjour; Andrea M Coverstone; Mario Castro; Fernando Holguin; Sally E Wenzel; Prescott G Woodruff; Eugene R Bleecker; John V Fahy
Journal:  Lancet Respir Med       Date:  2016-06-06       Impact factor: 30.700

7.  An asthma-associated IL4R variant exacerbates airway inflammation by promoting conversion of regulatory T cells to TH17-like cells.

Authors:  Amir Hossein Massoud; Louis-Marie Charbonnier; David Lopez; Matteo Pellegrini; Wanda Phipatanakul; Talal A Chatila
Journal:  Nat Med       Date:  2016-08-01       Impact factor: 53.440

Review 8.  Role of IL-6 in asthma and other inflammatory pulmonary diseases.

Authors:  Mercedes Rincon; Charles G Irvin
Journal:  Int J Biol Sci       Date:  2012-10-25       Impact factor: 6.580

9.  A regulatory T cell Notch4-GDF15 axis licenses tissue inflammation in asthma.

Authors:  Hani Harb; Emmanuel Stephen-Victor; Elena Crestani; Mehdi Benamar; Amir Massoud; Ye Cui; Louis-Marie Charbonnier; Sena Arbag; Safa Baris; Amparito Cunnigham; Juan Manuel Leyva-Castillo; Raif S Geha; Amirhosein J Mousavi; Boris Guennewig; Klaus Schmitz-Abe; Constantinos Sioutas; Wanda Phipatanakul; Talal A Chatila
Journal:  Nat Immunol       Date:  2020-09-14       Impact factor: 25.606

  9 in total
  1 in total

Review 1.  JAK inhibitors for asthma.

Authors:  Steve N Georas; Patrick Donohue; Margaret Connolly; Michael E Wechsler
Journal:  J Allergy Clin Immunol       Date:  2021-10       Impact factor: 10.793

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.